| abstract |
The invention belongs to the technology of skin medicine, in particular to the application of a hydroxybetulinic acid compound in the treatment of skin diseases, especially eczema, inflammatory skin diseases and anaphylactic shock. The present invention designs a variety of skin external administration formulations, including solutions, gels, ointments, patches, emulsions, and sprays for topical administration of various skin diseases. The advantages of small side effects, in particular, solve the problems of digestive tract toxicity and large dosage of existing oral drugs. Research shows that using the method of the present invention to treat skin diseases is not only effective, safe, and low in treatment cost, but also in a mouse model, the development of eczema and dermatitis can be suppressed, and anaphylactic shock can be relieved. |